KMT2A and acute myeloid leukemia: It was found that a stabilized, non-degradable mutant of NFκB-inducing kinase (NIK), a crucial mediator of non-canonical NFκB signaling, prolonged survival of MLL-AF9 AML mouse transplant recipients (136).